Author

Robert Strauss

ORCID 0000-0003-1777-7177Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alessandra FerriiD· 1 shared Claudia CirottiiD· 1 shared Claudia ContadiniiD· 1 shared Claudia Di GirolamoiD· 1 shared Daniela BarilàiD· 1 shared Donatella Del BufaloiD· 1 shared Giulia FisconiD· 1 shared J.S. WangiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandra FerriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer LettersPeer-reviewedNov 8, 2025

Caspase-8 is a novel modulator of Homologous Recombination Repair in response to ionizing radiations

Alessandra Ferri, Claudia Contadini, Claudia Di Girolamo…·Daniela Barilà

This study identifies Caspase-8 as a novel promoter of Homologous Recombination Repair in glioblastoma, enhancing DNA repair and resistance to ionizing radiation.

1 citation

mouseDrosophila

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 19, 2024

Glutamine-addiction in cisplatin resistant cancer cells is mediated by SLC7A11 and can be targeted with asparaginase therapy

J.S. Wang, Robert Strauss, Jiří Bártek, Sean G. Rudd

This study identifies SLC7A11 as a mediator of cisplatin resistance in cancer cells and shows asparaginase therapy can target this resistance.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky